Hematopoietic growth factor therapy of myelodysplastic syndromes.

作者信息

Arcenas A G, Vadhan-Raj S

机构信息

Department of Clinical Immunology and Biological Therapy, University of Texas M.D. Anderson Cancer Center, Houston 77030.

出版信息

Leuk Lymphoma. 1993;11 Suppl 2:65-9. doi: 10.3109/10428199309064264.

DOI:10.3109/10428199309064264

PMID:7510197

Abstract

摘要

相似文献

Hematopoietic growth factor therapy of myelodysplastic syndromes.

Leuk Lymphoma. 1993;11 Suppl 2:65-9. doi: 10.3109/10428199309064264.

Treatment of myelodysplastic syndromes with hemopoietic growth factors.

Semin Oncol. 1992 Feb;19(1):106-14.

Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.

Semin Hematol. 1996 Jul;33(3):186-95.

The role of haematopoietic growth factors in the treatment of myelodysplastic syndromes.

Hematol Oncol. 1993;11 Suppl 1:32-5.

The role of hematopoietic growth factors in the treatment of neoplastic diseases.

Semin Hematol. 1992 Jul;29(3 Suppl 2):53-63.

Treatment of myelodysplastic syndromes with hematopoietic growth factors.

Hematol Oncol Clin North Am. 1992 Jun;6(3):633-53.

[Clinical use of hematopoietic growth factors].

Pol Tyg Lek. 1992;47(16-17):365-8.

Aspects on the clinical use of hematopoietic growth factors in myelodysplastic syndromes.

Pol Arch Med Wewn. 1998 Feb;99(2):144-9.

A European perspective on haematopoietic growth factors in haemato-oncology: report of an expert meeting of the EORTC.

Eur J Cancer. 1997 Oct;33(11):1732-46. doi: 10.1016/s0959-8049(97)00222-0.

[Hematopoietic growth factors].

Postepy Hig Med Dosw. 1991;45(6):461-96.

引用本文的文献

Epoetin alfa. A review of its clinical efficacy in the management of anaemia associated with renal failure and chronic disease and its use in surgical patients.

Drugs Aging. 1995 Aug;7(2):131-56. doi: 10.2165/00002512-199507020-00007.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Hematopoietic growth factor therapy of myelodysplastic syndromes.

Leuk Lymphoma. 1993;11 Suppl 2:65-9. doi: 10.3109/10428199309064264.

Treatment of myelodysplastic syndromes with hemopoietic growth factors.

Semin Oncol. 1992 Feb;19(1):106-14.

Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.

Semin Hematol. 1996 Jul;33(3):186-95.

The role of haematopoietic growth factors in the treatment of myelodysplastic syndromes.

Hematol Oncol. 1993;11 Suppl 1:32-5.

The role of hematopoietic growth factors in the treatment of neoplastic diseases.

Semin Hematol. 1992 Jul;29(3 Suppl 2):53-63.

Treatment of myelodysplastic syndromes with hematopoietic growth factors.

Hematol Oncol Clin North Am. 1992 Jun;6(3):633-53.

[Clinical use of hematopoietic growth factors].

Pol Tyg Lek. 1992;47(16-17):365-8.

Aspects on the clinical use of hematopoietic growth factors in myelodysplastic syndromes.

Pol Arch Med Wewn. 1998 Feb;99(2):144-9.

A European perspective on haematopoietic growth factors in haemato-oncology: report of an expert meeting of the EORTC.

Eur J Cancer. 1997 Oct;33(11):1732-46. doi: 10.1016/s0959-8049(97)00222-0.

[Hematopoietic growth factors].

Postepy Hig Med Dosw. 1991;45(6):461-96.

引用本文的文献

Epoetin alfa. A review of its clinical efficacy in the management of anaemia associated with renal failure and chronic disease and its use in surgical patients.

Drugs Aging. 1995 Aug;7(2):131-56. doi: 10.2165/00002512-199507020-00007.